What are psychedelic substances? Why are they currently being researched in the medical field? Are psychedelics already available for treatment in Europe? These are some of the issues addressed in a new set of EUDA Frequently Asked Questions (FAQs): therapeutic use of psychedelic substances released today.
The FAQs are published in response to the growing interest in the therapeutic use of psychedelic substances and the need for reliable information on the topic. The digital resource is based on the findings from an EUDA project to develop a better understanding of key developments in this…
Čtěte více
Eliminating viral hepatitis as a public health threat by 2030 is a target set under the UN Sustainable Development Goal on Health (SDG 3.3) (1). Ahead of World Hepatitis Day on 28 July, the EUDA has released today an update of its interactive elimination barometer designed to support countries in monitoring their progress towards the elimination of viral hepatitis among people who inject drugs.
Hepatitis C virus (HCV) infection is the infectious disease associated with the highest burden of disease among people who inject drugs (PWID), the virus being easily transmitted through the…
Čtěte více
This week, a delegation from the newly established European Union Drugs Agency (EUDA) visited Washington DC for a series of high-level meetings with US partners. Led by EUDA Executive Director Alexis Goosdeel, the delegation aimed to present the agency's new mandate and discuss potential areas of cooperation within its new responsibilities. This was the first EUDA visit to the US and took place just one week after the official inauguration of the agency in Lisbon. Following a meeting at the EU Delegation to the United States, the visiting EUDA staff members met with the following entities:…
Čtěte více
High-ranking officials are gathering in Lisbon today for the inauguration of the new European Union Drugs Agency (EUDA). The new agency replaces the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), which has been operating in Lisbon since 1995. New legislation which entered into application this week revises the EMCDDA mandate and name, and formally establishes the EUDA (1). The transformation marks a pivotal step in strengthening the EU’s capacity to address the health and security challenges posed by illicit drugs.
Following an external evaluation of the EMCDDA, the…
Čtěte více
Cooperation with Ecuador was enhanced today following the signing of a Working Arrangement between the European Union Drugs Agency (EUDA) and the Ministry of Foreign Affairs and Human Mobility of Ecuador. The agreement was signed in Lisbon by EUDA Executive Director Alexis Goosdeel and H.E Xavier Aliaga Sancho, Ambassador and Head of the Mission of Ecuador to the European Union.
The signing ceremony took place in the presence of European Commissioner for Home Affairs, Ylva Johansson following the official inauguration of the EUDA this morning. The new agency replaces the European Monitoring…
Čtěte více
Today, the European Union Drugs Agency (EUDA) officially starts work in Lisbon replacing the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The development is the result of legislation entering into application today, which revises the EMCDDA mandate and name and formally establishes the EUDA (1). With new tools and competencies, the EUDA will play a key role in strengthening the EU's response to emerging health and security challenges posed by illicit drugs.
Why a new agency? Following an external evaluation of the EMCDDA, the European Commission called for a…
Čtěte více
Today, Mr James Browne, Minister of State at the Department of Justice, paid a visit to the EMCDDA where he met Director, Alexis Goosdeel.
The delegation toured the agency’s premises amidst preparations underway for the launch of the new European Union Drugs Agency (EUDA) on 2 July.
Mr Goosdeel provided an overview of the EMCDDA's history and the upcoming tasks of the EUDA. He explained how the EUDA would achieve its new goals under a new service model (‘anticipate, alert, respond and learn’).
Among the topics discussed at the meeting were the multi-faceted challenges of the drugs problem…
Čtěte více
